Cargando…

One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis

BACKGROUND: The main control strategy for visceral leishmaniasis in Brazil has been based on the elimination of seropositive dogs, although this is not widely accepted. In this context, the use of a long-lasting protective vaccine against canine visceral leishmaniasis (CVL) has been highly expected....

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa-Pereira, Christiane, Moreira, Marcela L, Soares, Rodrigo P, Marteleto, Bruno H, Ribeiro, Vitor M, França-Dias, Michelle H, Cardoso, Ludmila M, Viana, Kelvinson F, Giunchetti, Rodolfo C, Martins-Filho, Olindo A, Araújo, Márcio S S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405846/ https://www.ncbi.nlm.nih.gov/pubmed/25880646 http://dx.doi.org/10.1186/s12917-015-0397-6

Ejemplares similares

Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity
por: da Silva, João Guilherme Lino, et al.
Publicado: (2023)

The Program for the Control of Visceral Leishmaniasis in Brazil: The Effect of the Systematic Euthanasia of Seropositive Dogs as a Single Control Action in Porteirinha, a Brazilian City with an Intense Transmission of Visceral Leishmaniasis
por: França-Silva, João Carlos, et al.
Publicado: (2023)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

The role of mucosal-associated invariant T cells in visceral leishmaniasis
por: Moreira, Marcela de Lima, et al.
Publicado: (2022)

Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis
por: de Mendonça, Ludmila Zanandreis, et al.
Publicado: (2016)

Control of visceral leishmaniasis in Brazil: recommendations from Brasileish
por: Ribeiro, Vitor Márcio, et al.
Publicado: (2013)

Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster
por: González, Marco Antonio Cabrera, et al.
Publicado: (2023)

Nanoformulations with Leishmania braziliensis Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (Mesocricetus auratus) against Visceral Leishmaniasis
por: Ottino, Jennifer, et al.
Publicado: (2022)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Analysis using canine peripheral blood for establishing in vitro conditions for monocyte differentiation into macrophages for Leishmania chagasi infection and T-cell subset purification
por: Viana, Kelvinson Fernandes, et al.
Publicado: (2013)

Transmission-Blocking Vaccines for Canine Visceral Leishmaniasis: New Progress and Yet New Challenges
por: Leite, Jaqueline Costa, et al.
Publicado: (2023)

Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis
por: Resende, Lucilene Aparecida, et al.
Publicado: (2013)

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
por: Campi-Azevedo, Ana Carolina, et al.
Publicado: (2014)

Visceral leishmaniasis (kala-azar) and pregnancy.
por: Figueiró-Filho, Ernesto Antonio, et al.
Publicado: (2004)

An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy
por: Gonçalves, Ana Alice Maia, et al.
Publicado: (2019)

Phase I and II Clinical Trial Comparing the LBSap, Leishmune(®), and Leish-Tec(®) Vaccines against Canine Visceral Leishmaniasis
por: Aguiar-Soares, Rodrigo Dian de Oliveira, et al.
Publicado: (2020)

Canine visceral leishmaniasis in area with recent Leishmania transmission: prevalence, diagnosis, and molecular identification of the infecting species
por: Lopes, Josiane Valadão, et al.
Publicado: (2020)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

Visceral leishmaniasis and HIV coinfection: current perspectives
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2018)

Therapeutic Potential of Photosynthetic Microorganisms for Visceral Leishmaniasis: An Immunological Analysis
por: Vaitkevicius-Antão, Victor, et al.
Publicado: (2022)

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2016)

Risk Factors for Death in Children with Visceral Leishmaniasis
por: Sampaio, Márcia Jaqueline Alves de Queiroz, et al.
Publicado: (2010)

Is Visceral Leishmaniasis the same in HIV-coinfected adults?
por: Henn, Guilherme Alves de Lima, et al.
Publicado: (2018)

A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
por: Roatt, Bruno Mendes, et al.
Publicado: (2017)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Visceral Leishmaniasis Treatment, Italy
por: Gradoni, Luigi, et al.
Publicado: (2003)

The reemergence of visceral leishmaniasis in Brazil.
por: Arias, J R, et al.
Publicado: (1996)

Drug Resistance in Visceral Leishmaniasis
por: Maltezou, Helena C.
Publicado: (2010)

Is visceral leishmaniasis a sepsis or not?
por: Puca, E, et al.
Publicado: (2012)

Epidemiology of Visceral Leishmaniasis in Georgia
por: Babuadze, Giorgi, et al.
Publicado: (2014)

Therapeutic Options for Visceral Leishmaniasis
por: Monge-Maillo, Begoña, et al.
Publicado: (2013)

Visceral leishmaniasis with Roth spots
por: Meena, Jagdish, et al.
Publicado: (2014)

Epidemiology of visceral leishmaniasis in Georgia
por: Kokaia, Nora, et al.
Publicado: (2017)

The kinetoplast in the diagnosis of visceral leishmaniasis
por: Murray, Henry W.
Publicado: (2022)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019)

Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients
por: Gonçalves, Juan Jonathan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ppv58jmn9v999mah126h1ggdp2